Analysis News

  • The best newsletter in the market
  • Customisable and personal
  • By e-mail every morning, for free

Receive Analysis News:

EMail:

Free daily newsletter every morning

Content
Signals
All indicators - Medium term
Svenska Handelsbanken Jun 3, 2024
SandvikJun 3, 2024
Beijer Ref BJun 3, 2024
TRATON SEJun 3, 2024
Kindred Group SDBJun 3, 2024

OMX Stockholm PI moved more or less horizontally on Monday and closed at 992 points (+0.1 percent).

424 shares showed a gain and 525 showed a loss. 80 shares were unchanged and closed at the same price as the previous day. There was no trading in 51 shares.

Total value of the trading volume for shares and primary capital certificates Monday was approximately 123.1 billion.

OptiCept Technologies closed at 5.60 kronor after a gain of 30.8 percent, and broke the 5.00 -mark. Last time the stock was higher was Aug 2023. The stock has now risen for the fifth day in a row. The stock is with that up 69.7 percent after the buy signal from the double bottom formation two days ago. The volume was also high. At session end it was bought and sold shares for about 12 million kronor in the stock, which equals eight times mean daily turnover.
Precise Biometrics rose 35.2 percent and broke the 4.00 -mark. The close was at 4.51 kronor and the stock has not been higher since Jan 2023. The stock has thereby closed up six out of the past seven days and this past month the stock has gained as much as 205.9 percent. Technically it also looks good. The stock is trend wise positive in the medium term and a further increase is indicated.
Camurus gained 4.2 percent to 606 kronor. The stock thereby broke the previous record from Jan 16 and set a new all time high. This past week the stock has gained as much as 10.5 percent. It also looks good technically. The stock is trend wise positive in the medium term, has support at 530 kronor and a further increase is indicated.
Catena developed positively, and gained 2.1 percent to a close of 547 kronor. The stock has not closed higher since Apr 2022. This past month the stock has gained as much as 12.3 percent. Technically it also looks good. The stock is trend wise positive in the medium term, has support at 467 kronor and a further increase is indicated.
Hansa Biopharma rose 7.6 percent and broke the 50.00 -mark. The close was at 53.40 kronor and the stock has not been higher since Aug 2023. The stock has now risen for the fifth day in a row and this past month the stock has gained as much as 84.5 percent. The stock is trend wise negative in the medium term.

US 500 rises on Friday
The market moved up Friday, and S&P 500 ended at 5278 points, which is an increase of 0.8 percent. The week as a whole showed a loss of 0.5 percent. Overall May showed a gain of 4.8 percent.

Indices
OMX Stockholm PI
arrow green   Positive Candidate
OMX Stockholm PI shows strong development within a rising trend channel in the medium long term. Rising trends indicate that the market experiences positive development and that buy interest among investors is increasing. The price has risen strongly since the positive signal from the rectangle formation at the break through resistance at 828. The objective at 914 is now met, but the formation still gives a signal in the same direction. There is no resistance in the price chart and further rise is indicated. In case of a negative reaction, the index has support at approximately 862 points. RSI is above 70 after a good price increase the past weeks. The index has strong positive momentum and further increase is indicated. However, particularly for big stocks, high RSI may be a sign that the stock is overbought and that there is a chance of a reaction downwards. The index is overall assessed as technically positive for the medium long term.
S&P 500
arrow green   Positive Candidate
S&P 500 is in a rising trend channel in the medium long term. This signals increasing optimism among investors and indicates continued rise. The index has marginally broken up through resistance at points 5250. An established break predicts a further rise. RSI above 70 shows that the index has strong positive momentum in the short term. Investors have steadily paid more to buy the index, which indicates increasing optimism and that the price will continue to rise. However, particularly for big stocks, high RSI may be a sign that the stock is overbought and that there is a chance of a reaction downwards. The index is overall assessed as technically positive for the medium long term.
Today's candidate
Arise (ARISE) Price 50.10, Jun 3, 2024
chart
Arise has broken the falling trend channel in the medium long term and reacted strongly up. For the time being, it is difficult to say anything about the future trend direction. The price has risen strongly since the positive signal from the rectangle formation at the break through resistance at 41.35. The objective at 48.79 is now met, but the formation still gives a signal in the same direction. The stock has support at kronor 42.80 and resistance at kronor 57.50. Positive volume balance shows that volume is higher on days with rising prices than days with falling prices. This indicates increasing optimism among investors. RSI is above 70 after a good price increase the past weeks. The stock has strong positive momentum and further increase is indicated. The stock is overall assessed as technically positive for the medium long term.
Recommendation: Positive
Latest days indices
AEX0.16%905.10
CAC400.06%7998.02
COMPX-0.01%16735.00
DAX0.60%18608
HEX0.28%10273.00
N1000.29%1535.02
OMXC25GI-0.33%2287.86
OMXSPI0.09%991.74
OSEBX0.13%1442.35
PSI200.46%6870.81
TECDAX0.94%3367.64
BUK100P-0.12%824.85
EURUSD0.35%1.0900
CL (OIL)-1.18%76.99
Indices Evaluations
 SML
AEXpospospos
CAC40neutralpospos
COMPXpospospos
DAXpospospos
HEXposnegneg
N100posneutralpos
OMXC25GIpospospos
OMXSPIpospospos
OSEBXpospospos
PSI20neutralpospos
TECDAXnegpospos
BUK100Ppospospos
EURUSDposposneutral
CL (OIL)negnegneutral

S: Short term.    M: Medium term.    L: Long term.
Stock Exchange barometer
Stockholmsbörsen - Medium term
 
      
39% 44% 17%
 442 Buy Candidates
 493 Neutral
 188 Sell Candidates
Track what the insiders are doing! Insider buys in green, insider sales in red.
 
   Last month:
   79% Positive
   599 Positive
   161 Negative
Disclaimer Copyright © 2024 Investtech.com AS, Org nr 978 655 424 MVA


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Cancel Analysis News
[ Back to default newsletter setup ]

Edit AnalysisNews

Register as a recipient of AnalysisNews in order to customise the content.
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

×

Please login here

 
Forgot your password?

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.

Our use of cookies

When you use our website, we store a cookie on your device. The cookie is used to recognize your device so that your settings work when you use our websites. The information that is stored is completely anonymised. Cookies are automatically deleted after a certain time.

Necessary cookies

Investtech uses cookies to ensure basic functions such as page navigation and language selection. Without such cookies, the website does not function as it should. You cannot therefore make a reservation against these. If you still want to disable such cookies you can do so in your browser settings. In the Cookies section add this website to the list of sites which are not allowed to save cookies on your device.

Cookies from Google

We use services from Google Analytics and Google AdWords. These register cookies on your device when you visit our website. Google registers your IP address in order to keep statistics on user activity on the website. The IP address is anonymised, so that we have no opportunity to link the activities to a specific person. We use these statistics to be able to offer more interesting content on the website and to constantly improve ourselves. Google AdWords collects data so that our advertising on other websites gives better results. We cannot trace the data of individuals.

Allow cookies from Google